Phase 1 study on the safety and efficacy of E6011, antifractalkine antibody, in patients with Crohn's disease

Katsuyoshi Matsuoka, Makoto Naganuma, Toshifumi Hibi, Hirohito Tsubouchi, Kiyoshi Oketani, Toshinori Katsurabara, Seiichiro Hojo, Osamu Takenaka, Tetsu Kawano, Toshio Imai, Takanori Kanai

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'Phase 1 study on the safety and efficacy of E6011, antifractalkine antibody, in patients with Crohn's disease'. Together they form a unique fingerprint.

Medicine & Life Sciences